JBIO
Ensign Peak Advisors’s Jade Biosciences, Inc. Common Stock JBIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-262,257
| Closed | -$7.75M | – | 1715 |
|
|
2024
Q1 | $7.75M | Buy |
262,257
+140,000
| +115% | +$4.14M | 0.01% | 513 |
|
|
2023
Q4 | $2.77M | Buy |
122,257
+107,257
| +715% | +$2.43M | 0.01% | 792 |
|
|
2023
Q3 | $204K | Hold |
15,000
| – | – | ﹤0.01% | 1725 |
|
|
2023
Q2 | $257K | Hold |
15,000
| – | – | ﹤0.01% | 1726 |
|
|
2023
Q1 | $303K | Sell |
15,000
-6,208
| -29% | -$125K | ﹤0.01% | 1713 |
|
|
2022
Q4 | $621K | Buy |
+21,208
| New | +$621K | ﹤0.01% | 1536 |
|